| Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information JC Bélisle Pipon, B Williams-Jones Journal of Bioethical Inquiry 12 (2), 259-267, 2015 | 13 | 2015 |
| Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly’s Canadian 40over40 Erectile Dysfunction Campaign JC Bélisle Pipon, B Williams-Jones Healthcare Policy 10 (4), 16-22, 2015 | 9 | 2015 |
| Early-career researchers’ views on ethical dimensions of patient engagement in research JC Bélisle-Pipon, G Rouleau, S Birko BMC medical ethics 19 (1), 21, 2018 | 7 | 2018 |
| Duty to inform and informed consent in diagnostic radiology: how ethics and law can better guide practice V Doudenkova, JCB Pipon HEC forum 28 (1), 75-94, 2016 | 6 | 2016 |
| Ethics education in public health: where are we now and where are we going? V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ... International Journal of Ethics Education, 2017 | 4 | 2017 |
| Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public B Williams-Jones, JC Bélisle-Pipon, L Ringuette, AI Cloutier, ... Autour de l’intégrité scientifique, la loyauté, et la probité : aspects …, 2016 | 4 | 2016 |
| De la binarité au modèle AI3R : la bioéthique écosystémique comme modèle d’analyse normative de l’industrie biopharmaceutique JC Bélisle Pipon Université de Montréal, 2013 | 4 | 2013 |
| Early career researchers’ perspectives and roles in patient-oriented research G Rouleau, JC Bélisle-Pipon, S Birko, P Karazivan, N Fernandez, ... Research Involvement and Engagement 4 (1), 35, 2018 | 3 | 2018 |
| Protecting public health or commercial interests? The importance of transparency during immunization campaigns JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones Ethics, Medicine and Public Health, 2017 | 3 | 2017 |
| Patients as Research Partners; How to Value their Perceptions, Contribution and Labor? E Smith, JC Bélisle-Pipon, D Resnik Citizen Science 4 (1), 1-13, 2019 | 2 | 2019 |
| Améliorer la compréhension et la gestion des conflits d’intérêts des experts conseillant la prise de décisions en santé publique AI Cloutier, JC Bélisle-Pipon, L Ringuette, V Doudenkova, ... BioéthiqueOnline 5 (38), 1-5, 2016 | 2 | 2016 |
| Art + Bioéthique : quand la recherche en bioéthique quitte les murs de l’université V Couture, JC Bélisle-Pipon, M Laliberté BioéthiqueOnline 5 (16), 2016 | 2 | 2016 |
| Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations JC Bélisle Pipon, B Williams-Jones Canadian Medical Association Journal 188 (5), 319-320, 2016 | 2* | 2016 |
| Visées éthiques, développement et usage du médicament JS Fortin, JC Bélisle-Pipon, I Ganache Précis de pharmacologie, 1011-1021, 2015 | 2 | 2015 |
| Ethical challenges of open-access publishing B Williams-Jones, JC Bélisle-Pipon, E Smith, R Boulanger University Affairs, 2014 | 2 | 2014 |
| “What Is PER?” Patient Engagement in Research as a Hit JC Bélisle-Pipon, C Del Grande, G Rouleau Canadian Journal of Bioethics 1 (2), 59-62, 2018 | 1 | 2018 |
| Dear DTCA, Please Don’t Deceive Me, Don’t Play on My Fantasy JC Bélisle-Pipon BioéthiqueOnline 5, 2016 | 1 | 2016 |
| Between Policy and Politics: When Bioethics Ventures into Public Debate JCB Pipon, MÈ Lemoine, M Laliberté, B Williams–Jones Narrative inquiry in bioethics 6 (1), 3-6, 2016 | 1 | 2016 |
| Research ethics and commercial drug development: when integrity threatens profitability JC Bélisle Pipon BioéthiqueOnline 5, 2016 | 1 | 2016 |
| Les enjeux éthiques de la limite des ressources en santé J Saint-Arnaud, B Godard, JC Bélisle Pipon Presses de l'Université de Montréal, 2016 | 1 | 2016 |
Bryn Williams-Jones, PhDBioethics Program, Department of Social and Preventive Medicine, School of Public Health, U.MontrealVerified email at umontreal.ca